Professor Gil Bar-Sela is a graduate of the Faculty of Medicine at Ben-Gurion University in Beer-Sheva, Israel. He obtained his Oncology training at Rambam Health Care Campus [RHCC] in Haifa, Israel. In 2003, he received Board certification in Medical and Radiation Oncology. During 2005-06 he worked in research at the Radiation Oncology Branch of the National Cancer Institute in Bethesda USA. In 2013, he received board certification in Palliative medicine- as one of the founders in this area in Israel. He is currently a Clinical Associated Professor at the Bruce Rapapport Faculty of Medicine of Technion, Haifa. His main Research Interests are: Palliative and supportive care in oncology, Complementary/integrated medicine in oncology, Basic and clinical research of chemotherapy side effects and the clinical area of Sarcoma and Melanoma. In those research areas he published, until mid- 2015 over 90 papers in medical journals and books.
Prof. Bar-Sela is also serves as the Deputy Director of the Division of Oncology at RHCC, head of the Palliative and Supportive Oncology Unit, and head of the Service for Melanoma and Sarcoma patients. He is currently a member of the Advisory Committee of the Israel Cancer Association on Palliative Care and Complementary Medicine. He is also a member of the “Survivorship Committee” of the National Council for the Prevention, Diagnosis & Treatment of Cancer.